Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Neoplasms

angiotensin ii, des-phe(8)- has been researched along with Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Costa, LB; de Paula Gonzaga, ALAC; de Sá Rodrigues, KE; Palmeira, VA; Ribeiro, TFS; Simões-E-Silva, AC	1
Arter, AL; Deng, G; Gallagher, PE; Tallant, EA	1
Aboye, T; Camarero, JA; Majumder, S; Meeks, CJ; Rodgers, K; Shekhtman, A	1
Machado-Silva, A; Passos-Silva, D; Santos, RA; Sinisterra, RD	1
Gallagher, PE; McCoy, TP; Miller, AA; Petty, WJ; Tallant, EA; Torti, FM	1

Reviews

3 review(s) available for angiotensin ii, des-phe(8)- and Neoplasms

Article	Year
ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors. Current drug targets, 2020, Volume: 21, Issue:9 Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Child; Humans; Neoplasms; Pediatrics; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System	2020
Angiotensin-(1-7): a peptide hormone with anti-cancer activity. Current medicinal chemistry, 2014, Volume: 21, Issue:21 Topics: Amino Acid Sequence; Angiotensin I; Animals; Antineoplastic Agents; Cell Proliferation; Clinical Trials as Topic; Humans; Neoplasms; Peptide Fragments; Peptide Hormones	2014
Therapeutic uses for Angiotensin-(1-7). Expert opinion on therapeutic patents, 2016, Volume: 26, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Clinical Trials as Topic; Drug Design; Humans; Neoplasms; Patents as Topic; Peptide Fragments; Renin-Angiotensin System	2016

Trials

1 trial(s) available for angiotensin ii, des-phe(8)- and Neoplasms

Article	Year
Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone. Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Dec-01, Volume: 15, Issue:23 Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiotensin I; Biomarkers, Tumor; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Peptide Fragments; Peptides	2009

Article

Year

Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Dec-01, Volume: 15, Issue:23

Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiotensin I; Biomarkers, Tumor; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Models, Biological; Neoplasms; Peptide Fragments; Peptides

2009

Other Studies

1 other study(ies) available for angiotensin ii, des-phe(8)- and Neoplasms

Article	Year
Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity. Molecules (Basel, Switzerland), 2016, Jan-26, Volume: 21, Issue:2 Topics: Angiotensin I; Animals; Cell Survival; CHO Cells; Cricetulus; Cyclotides; Humans; Myocardial Infarction; Neoplasms; Peptide Fragments; Plant Proteins; Protein Conformation; Protein Folding; Protein Stability; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled	2016

Article

Year

Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity.

Molecules (Basel, Switzerland), 2016, Jan-26, Volume: 21, Issue:2

Topics: Angiotensin I; Animals; Cell Survival; CHO Cells; Cricetulus; Cyclotides; Humans; Myocardial Infarction; Neoplasms; Peptide Fragments; Plant Proteins; Protein Conformation; Protein Folding; Protein Stability; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled

2016